Logo1

Mirzaev KB, Osipova DV, Kitaeva EJ, Shprakh VV, Abdullaev SP, Andreev DA, Mumladze RB, Sychev DA.
Effects of the rs2244613 polymorphism of the CES1 gene on the antiplatelet effect of the receptor P2Y12 blocker clopidogrel.
Drug Metab Pers Ther. 2019:1-8. Sep 27.
doi: 10.1515/dmpt-2018-0039.

 

скачать материал

Mirzaev KB, Fedorinov DS, Ivashchenko DV, Sychev DA.
ADME pharmacogenetics: future outlook for Russia.
Pharmacogenomics. 2019 Jul;20(11):847-865.

doi: 10.2217/pgs-2019-0013.

 

скачать материал

Zastrozhin M, Skryabin V, Smirnov V, Grishina E, Ryzhikova K, Chumakov E, Sychev D, Bryun E.
Effects of CYP2D6 activity on the efficacy and safety of mirtazapine in patients with depressive disorders and comorbid alcohol use disorder.
Can J Physiol Pharmacol. 2019 May

скачать материал

17. doi: 10.1139/cjpp-2019-0177. [Epub ahead of print]

Zastrozhin MS, Skryabin VY, Miroshkin SS, Bryun EA, Sychev DA.
Pharmacogenetics of alcohol addiction: current perspectives.
The Application of Clinical Genetics 2019, 12:131-140

DOI https://doi.org/10.2147/TACG.S206745

скачать материал

Mirzaev KB, Samsonova KI, Potapov PP, Andreev DA, Grishina EA, Ryzhikova KA, Sychev DA.
Genotyping and phenotyping CYP3A4\CYP3A5: no association with antiplatelet effect of clopidogrel.
Mol Biol Rep. 2019 May 17.

 

doi: 10.1007/s11033-019-04871-y. [Epub ahead of print]

скачать материал